Has Lorely Mendez received payments from drug or device companies?

Yes. Drug and device makers reported $58 in general payments to Lorely Mendez across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lorely Mendez did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lorely Mendez come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lorely Mendez

General Practice · Miami Gardens, FLNPI 1316141443

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Pfizer accounts for 71.6% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for general practice clinicians in FL, where the typical reported total is $253.

$58in general payments, 2019–2025

Across 3 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$42
AstraZeneca$16

$621,074in research payments, 2019–2025

Across 57 payments — averaging $10,896 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Teva Pharmaceuticals USA, Inc.$586K
E.r. Squibb & Sons, L.L.C.$32K
Supernus Pharmaceuticals, Inc.$3K

What the payments were for

Food & beverage$58100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	2	$42
AstraZeneca	1	$16

How this compares

$58 in reported general payments places this provider in the 20th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Atorvastatin Calcium	117	$825
Losartan Potassium	62	$712
Nifedipine ErNifedipine	13	$375
Lisinopril	42	$211
Metformin Hcl	43	$191
Metoprolol Succinate	13	$162
Omeprazole	25	$152
Rosuvastatin Calcium	16	$144
Amlodipine Besylate	55	$138
Tamsulosin Hcl	11	$132
Hydrochlorothiazide	45	$122
Glipizide	21	$112
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide	13	$108
Pantoprazole Sodium	13	$103
Simvastatin	17	$68

Paid to pharmacies, not to this prescriber.

Other general practice in Miami Gardens

Robert VogelPalm Beach Gardens$1M
Bruce OuelletteWest Palm Beach$724K
Caley CasteleinMiami Beach$586K
Sarah JockinTampa$308K
Mario RomeroSarasota$275K
Robert RitterJupiter$233K
Robert AltharPensacola$231K
Florencia ZiemkeWest Palm Beach$208K
Ausberto HidalgoPembroke Pines$171K
Rickie FergusonPembroke Pines$170K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →